Health Sciences Acquisitions Corporation 2
HSAQNASDAQFinancial Services
$13.31
+$2.59(+24.16%)
Market Cap$149233051
P/E Ratio—
52W High$13.8
52W Low$9.41
Health Sciences Acquisitions Corporation 2 (HSAQ) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · HSAQ · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2022-12 | 2021-12 | 2020-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $33.48M | $2.64M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $0.19M | $0.20M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $33.29M | $2.43M | $0.00M | $0.00M | $0.00M |
| Gross Margin %(computed) | 99.43% | 92.27% | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $58.19M | $42.80M | $0.00M | $0.00M | $0.00M |
| G&A Expenses | $0.00M | $0.00M | $2.96M | $0.27M | $0.13M |
| Total Operating Expenses | $85.10M | $66.73M | $2.96M | $0.27M | $0.18M |
| Operating Income | ($51.81M) | ($64.30M) | ($3.08M) | ($0.39M) | ($0.17M) |
| Operating Margin %(computed) | -154.73% | — | — | — | — |
| Interest Income | $0.00M | $0.00M | $0.35M | $0.02M | $0.00M |
| Interest Expense | ($1.15M) | $0.00M | ($0.35M) | ($0.02M) | $0.00M |
| Income Before Tax | ($52.95M) | ($61.02M) | ($2.74M) | ($0.38M) | ($0.17M) |
| Income Tax Expense | $0.00M | $0.00M | ($0.35M) | ($0.02M) | $0.00M |
| Net Income | ($52.95M) | ($61.02M) | ($2.39M) | ($0.36M) | ($0.17M) |
| Net Margin %(computed) | -158.16% | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.11 | $-1.66 | $-0.15 | $-0.02 | $-0.01 |
| Wtd Avg Shares | 38392.72M | 36821.04M | 16.43M | 20.27M | 20.27M |
| EBITDA | ($51.81M) | ($64.30M) | ($2.74M) | ($0.38M) | ($0.17M) |
| EBITDA Margin %(computed) | -154.73% | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Health Sciences Acquisitions Corporation 2 data
About Health Sciences Acquisitions Corporation 2 (HSAQ) Income Statement
Health Sciences Acquisitions Corporation 2 (HSAQ) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, HSAQ reported revenue of $0.03B, gross profit of $0.03B (gross margin 99.43%), and net income of ($0.05B) — a net profit margin of -158.16%.
Frequently asked questions
HSAQ · 4 questionsHealth Sciences Acquisitions Corporation 2 (HSAQ) reported revenue of $0.03B for 2025, up 1169.2% year-over-year.
HSAQ revenueHSAQ salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09